Waverley Pharma Inc. (FRA:5GZ)
0.0060
0.00 (0.00%)
Last updated: Nov 28, 2025, 9:59 AM CET
Waverley Pharma Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 0.07 | 0.24 | 0.05 | 0.13 | 0.16 | 0.71 | Upgrade |
Cash & Short-Term Investments | 0.07 | 0.24 | 0.05 | 0.13 | 0.16 | 0.71 | Upgrade |
Cash Growth | -71.74% | 345.02% | -60.38% | -15.38% | -77.75% | -51.91% | Upgrade |
Accounts Receivable | 0.05 | 0.05 | 0.14 | 0.19 | 0.42 | 0.45 | Upgrade |
Other Receivables | 0 | 0.16 | 0 | 0 | 0.28 | 0.01 | Upgrade |
Receivables | 0.06 | 0.21 | 0.14 | 0.19 | 0.7 | 0.46 | Upgrade |
Inventory | 0.26 | 0.26 | 0 | 0.06 | 0.33 | 0.27 | Upgrade |
Prepaid Expenses | 0.01 | 0.02 | 0.22 | 0.24 | 0.26 | 0.25 | Upgrade |
Total Current Assets | 0.39 | 0.73 | 0.42 | 0.63 | 1.45 | 1.68 | Upgrade |
Property, Plant & Equipment | 0.23 | 0.26 | - | - | - | - | Upgrade |
Goodwill | 0.22 | 0.22 | - | - | - | - | Upgrade |
Other Intangible Assets | 0.34 | 0.4 | - | 1.68 | 1.76 | 1.81 | Upgrade |
Other Long-Term Assets | 0.09 | 0.43 | 0.54 | 0.38 | 0.48 | - | Upgrade |
Total Assets | 1.27 | 2.05 | 0.95 | 2.69 | 3.68 | 3.49 | Upgrade |
Accounts Payable | 0.41 | 0.96 | 0.45 | 0.72 | 1.03 | 0.83 | Upgrade |
Accrued Expenses | - | - | - | 0.17 | 0.59 | 0.58 | Upgrade |
Short-Term Debt | 2.99 | 2.81 | 1.6 | 0.66 | 0.22 | - | Upgrade |
Current Portion of Long-Term Debt | - | - | - | 0.04 | 0.04 | - | Upgrade |
Current Portion of Leases | 0.04 | 0.04 | - | - | - | - | Upgrade |
Other Current Liabilities | 0 | 0.05 | 0.04 | 0 | 0.02 | - | Upgrade |
Total Current Liabilities | 3.45 | 3.86 | 2.09 | 1.6 | 1.89 | 1.41 | Upgrade |
Long-Term Debt | - | - | - | - | - | 0.04 | Upgrade |
Long-Term Leases | 0.19 | 0.22 | - | - | - | - | Upgrade |
Total Liabilities | 3.64 | 4.08 | 2.09 | 1.6 | 1.89 | 1.45 | Upgrade |
Common Stock | 7 | 7 | 7 | 7 | 7 | 7 | Upgrade |
Additional Paid-In Capital | 0.81 | 0.81 | 0.81 | 0.81 | 0.81 | 0.81 | Upgrade |
Retained Earnings | -10.64 | -10.34 | -9.4 | -7.17 | -6.51 | -5.71 | Upgrade |
Comprehensive Income & Other | 0.47 | 0.5 | 0.45 | 0.45 | 0.49 | -0.06 | Upgrade |
Shareholders' Equity | -2.36 | -2.03 | -1.14 | 1.09 | 1.79 | 2.04 | Upgrade |
Total Liabilities & Equity | 1.27 | 2.05 | 0.95 | 2.69 | 3.68 | 3.49 | Upgrade |
Total Debt | 3.22 | 3.07 | 1.6 | 0.7 | 0.26 | 0.04 | Upgrade |
Net Cash (Debt) | -3.16 | -2.83 | -1.55 | -0.57 | -0.1 | 0.67 | Upgrade |
Net Cash Growth | - | - | - | - | - | -54.62% | Upgrade |
Net Cash Per Share | -0.06 | -0.05 | -0.03 | -0.01 | -0.00 | 0.01 | Upgrade |
Filing Date Shares Outstanding | 54 | 54 | 54 | 54 | 54 | 54 | Upgrade |
Total Common Shares Outstanding | 54 | 54 | 54 | 54 | 54 | 54 | Upgrade |
Working Capital | -3.05 | -3.13 | -1.67 | -0.96 | -0.45 | 0.27 | Upgrade |
Book Value Per Share | -0.04 | -0.04 | -0.02 | 0.02 | 0.03 | 0.04 | Upgrade |
Tangible Book Value | -2.92 | -2.65 | -1.14 | -0.59 | 0.03 | 0.23 | Upgrade |
Tangible Book Value Per Share | -0.05 | -0.05 | -0.02 | -0.01 | 0.00 | 0.00 | Upgrade |
Machinery | - | 0.01 | - | - | - | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.